Biotech nation – where next for China’s innovation in the therapies sector?
Friday, March 27, 2020
China has become one of the world’s leading biotech nations, driven in part by Beijing’s desire to improve its domestic healthcare sector and its need to lower medical costs in the face of a rapidly ageing population. What are the themes and trends of this sector, and where are the next growth opportunities? Should China’s biotech firms focus on innovating for China – or for the world? And how has 2018’s uneven biotech IPO performance out of Hong Kong affected capital-raising? Our panel of industry innovators will tackle these questions and more.